|
|
Article: MabCure Inc. Featured in GEN (Genetic Engineering & Biotechnology News).
- Article from:
- Business Wire
- Article date:
- September 8, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company CEO Dr. Amnon Gonenne Contributes Article To September Issue
HASSELT, Belgium -- MabCure, Inc. ("MabCure"), a diagnostic company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, is featured in the September issue of GEN (Genetic Engineering & Biotechnology News). The article, written by MabCure CEO, Dr. Amnon Gonenne, entitled "Searching for Appropriate Cancer Biomarkers," describes how tumor-specific antibodies could positively impact diagnosis, imaging, and therapy.
"Cancer biomarker discovery has been hampered by the heterogeneity of the diseases known as cancer," Dr. Gonenne ...